CDI Laboratories

CDI Laboratories is an established biotechnology service provider with a focus on proteome-scale discovery tools. Its core offerings include the HuProt Human Proteome Microarray, VirD Functional Membrane Protein Microarray, and PhIP-Seq-based services (VirScan, HuScan, MouseScan) for epitope-level profiling. The company serves academic, biopharma, and diagnostic clients by enabling large-scale autoantibody detection and therapeutic target deconvolution. Its business model is built on providing specialized CRO services and proprietary research platforms to accelerate external R&D programs.

Suite of high-throughput proteomic platforms including the HuProt Human Proteome Microarray (full-length folded proteins), VirD Functional Membrane Protein Microarray, and PhIP-Seq-based services (VirScan, HuScan, MouseScan) for epitope-level antibody profiling.

CDI Labs competes in the crowded life sciences tools and services market. Key competitors include large diversified CROs (e.g., LabCorp, IQVIA), specialty proteomics companies (e.g., Somalogic, Olink prior to acquisition), and academic core facilities offering similar array or sequencing services. Its differentiation lies in the combination of full-length protein microarrays, functional membrane protein assays, and PhIP-Seq under one roof, offering a unique breadth of proteome-scale interaction analysis.